Trademark Overview
On Thursday, October 12, 2023, a trademark application was filed for VITALX with the United States Patent and Trademark Office. The USPTO has given the VITALX trademark a serial number of 98221714. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, June 19, 2024. This trademark is owned by InflammaSense, Inc. The VITALX trademark is filed in the Medical Instrument Products category with the following description:
Medical devices for use in treating or diagnosing sepsis and inflammatory disease using a non-invasive patch to record and measure biological signs, cytokine signals and neural signals; Medical devices for use in treating or diagnosing sepsis and inflammatory disease using a non-invasive patch to record and measure biological signs, cytokine signals and neural signals with integrated recorded operating system software, sold as a unit; Medical devices for use in treating or diagnosing sepsis and inflammatory disease using a non-invasive patch to record and measure biological signs, cytokine signals and neural signals with integrated recorded software using artificial intelligence, machine learning, and deep learning to decode nervous system language response signals to detect sepsis and inflammatory disease, sold as a unit
